Kerecis requests that their press release NewsItemId: 20250603277113 issued June 3, 2025 "Blue Cross and Blue Shield of ...

Kerecis has launched SurgiClose Silicone, a product combining fish-skin graft with silicone backing to treat surgical and trauma wounds. There are two variants available for this device ...

Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration, today announced that Cigna, one of the largest health insurers in ...

SAWC is currently taking place in Las Vegas through October 5, 2024. The Kerecis booth is number 517. Kerecis will release an important announcement regarding exciting new research tomorrow ...

Product combines fish-skin grafts and silicone for soft-tissue repair Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue ...

Coloplast A/S is acquiring Kerecis hf, a closely held Icelandic maker of fish-skin dressings to treat human wounds, for an enterprise value of up to $1.3 billion. Coloplast is making a $1.2 ...

Janalynn Miller, who works with Parkview Physicians Group’s wound care division, was named a 2025 Aurora Award winner by Kerecis, an Iceland-based company that specializes in using fish skin ...

Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, ...

The decision provides access to Kerecis’ intact fish-skin technology for more than 1.6 million BCBSLA members, marking a meaningful expansion of regenerative wound care in the Gulf South.